The effect of intravenous Vitamin B6 administration in Prevention of nausea and vomiting due to chemotherapy in pediatrics.

The effect of intravenous Vitamin B6 administration in Prevention of chemotherapy induced nausea and vomiting in children with malignancy.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150119020715N8

Enrollment

100

Registered

2018-07-22

Start date

2017-04-21

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nausea and vomiting. Nausea with vomiting, unspecified

Interventions

Intervention 1: Intervention group: In a cycle of chemotherapy for the patient, in addition to the use of Granisetron (3 mg / 3 ml), injected into the sample for a half-hour before the chemotherapy wa

Eligibility

Sex/Gender

All

Age

2 Years to 15 Years

Inclusion criteria

Inclusion criteria: desire to participate in the study Children with malignancy who need to chemotherapy 2 to 15 years of age

Exclusion criteria

Exclusion criteria: Unwilling to participate in the study patients with Immune deficiency patients with cardiovascular disease patients with AIDS patients with renal failure patients with diabetes

Design outcomes

Primary

Measure	Time frame
Nausea and vomiting. Timepoint: The frequency of nausea and vomiting is recorded within 24 hours. Method of measurement: Recorded in checklist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Aziz Eghbali

Arak University of Medical Sciences

aziz_eghbali@yahoo.com+98 86 3313 4715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026